Obesity drug semaglutide fails to slow Alzheimers - BBC Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer's - despite initial hopes that it might help against dementia Researchers
Weight-loss drug falls short in Alzheimer’s study Weight-loss drug falls short in Alzheimer’s study Image (c) ConsumerAffairs New trials show semaglutide failed to slow cognitive decline in Alzheimer's, despite improving biomarkers
Semaglutide fails to slow Alzheimers in clinical trial Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as two-year clinical trials end in disappointment for patients, medical